New product could aid successful production of mRNA therapeutics
Drug Discovery World
MAY 21, 2024
PrimeCap T7 RNA Polymerase is a mutant T7 RNA polymerase that has been genetically engineered to maintain high-performance RNA synthesis activity while reducing dsRNA production to less than 10%. We are thrilled to launch this enzyme which will remove both the technical and financial barriers to the successful production of mRNA therapeutics.”
Let's personalize your content